Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Oakden, W. K. Articles by Noseworthy, M. D. Search for Related Content PubMed PubMed Citation Articles by Oakden, W. K. Articles by Noseworthy, M. D.

American Journal of Neuroradiology 26:1571-1574, June-July 2005
© 2005 American Society of Neuroradiology

PEDIATRICS

¹H MR Spectroscopic Characteristics of Kernicterus: A Possible Metabolic Signature

Wendy K. Oakden^a,c, Aideen M. Moore^d, Susan Blaser^c,e and Michael D. Noseworthy^a,b,e

^a Imaging Research Centre, Brain Body Institute, St Joseph’s Healthcare, Hamilton, Ontario, Canada
^b Departments of Radiology and Medical Physics and Applied Radiation Sciences, McMaster University, Hamilton, Ontario, Canada
^c Department of Diagnostic Imaging, University of Toronto, Ontario, Canada
^d Department of Neonatology, the Hospital for Sick Children, University of Toronto, Ontario, Canada
^e Department of Medical Imaging, University of Toronto, Ontario, Canada

Address correspondence to Michael D. Noseworthy, PhD, Imaging Research Centre, St Joseph’s Healthcare, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada

BACKGROUND AND PURPOSE: MR examination of infants with kernicterus shows abnormal changes in signal intensity in various parts of the brain, including the globus pallidus and subthalamic regions. The purpose of this study was to retrospectively analyze proton (¹H) MR spectroscopic data to see if the MR spectroscopic profiles of infants with hyperbilirubinemia and symptoms of kernicterus provide new insights into the pathophysiology of bilirubin neurotoxicity.

METHODS: Six patients aged 3 days to 3 weeks, with hyperbilirubinemia and symptoms of kernicterus underwent MR imaging and MR spectroscopy with a single-voxel point-resolved spectroscopic sequence. The voxel of interest was centered in the basal ganglia with CSF excluded. Quantitative analysis was done by using LCModel. Between-subject comparisons were based on metabolite ratios relative to creatine.

RESULTS: Ratios of taurine, glutamate and glutamine, and myoinositol relative to creatine were significantly elevated (P < .001), whereas the ratio of choline to creatine was significantly decreased (P < .001) compared with normal values published for this age group. Lactate levels were not significantly elevated.

CONCLUSION: Kernicterus has a characteristic signature that is detectable on ¹H-MR spectroscopy. Our results are generally in agreement with what is known about bilirubin pathology, and the finding of increased glutamate and glutamine and decreased choline ratios indicates a possible link between hepatic encephalopathy and kernicterus. This observation may help in elucidating the pathophysiology of bilirubin neurotoxicity.